COMMUNIQUÉS West-GlobeNewswire

-
Agritek Holdings, Inc. Announces Purchase And Transfer Of Tier One Recreational License For Colorado On Behalf Of Approved Partner Licensee With Existing Cannabis Operations
26/04/2018 - 14:30 -
William Hartman, CEO of Premier Biomedical, Returns to Uptick Newswire’s “Stock Day” Podcast
26/04/2018 - 14:30 -
Alder BioPharmaceuticals® Appoints Jeremy Green to its Board of Directors
26/04/2018 - 14:30 -
Imagin Gains Momentum; Positive Progress in Research Study
26/04/2018 - 14:30 -
Histogenics Corporation to Report First Quarter 2018 Financial Results on May 10, 2018
26/04/2018 - 14:30 -
Navamedic ASA: Strengthens international IP position with two new patents in the U.S.
26/04/2018 - 14:22 -
PolarityTE Leadership to Participate in the Symposium on Advanced Wound Care
26/04/2018 - 14:15 -
Aino Health AB (publ): Aino Health gains representation in the United Arab Emirates
26/04/2018 - 14:01 -
Achaogen Wins CARB-X Funding Award to Advance Development of Novel Aminoglycoside to Fight Highly-Resistant Infections
26/04/2018 - 14:01 -
Rexahn to Present Clinical Data at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
26/04/2018 - 14:00 -
PositiveID’s Chairman and CEO Addresses Stockholders
26/04/2018 - 14:00 -
Aduro Biotech Presents Early Observations From its Personalized Neoantigen-based pLADD Therapy Clinical Study at European Neoantigen Summit
26/04/2018 - 14:00 -
Tauriga Sciences Inc. Announces Cancellation of Final Remaining Back-End Convertible Debenture Held by GS Capital Partners LLC in Connection with the $105,000 Face Value 8% Convertible Debenture Dated October 17, 2017
26/04/2018 - 14:00 -
BioNovelus Receives Organic Certification for CR-10®
26/04/2018 - 14:00 -
INSYS Therapeutics and University of California (UC) San Diego Center for Medicinal Cannabis Research to Collaborate on Clinical Trial
26/04/2018 - 14:00 -
Krystal Biotech Announces FDA Clearance of IND on KB103 to Begin Enrolling Patients for the Treatment of Dystrophic Epidermolysis Bullosa
26/04/2018 - 14:00 -
Poseida Therapeutics Presents Clinical Manufacturing Method for Durable, Persistent CAR-T Stem Cell Memory Therapies at World Orphan Drug Congress USA
26/04/2018 - 14:00 -
The Joint Corp. to Host Conference Call on Thursday, May 10, to Discuss First Quarter 2018 Results
26/04/2018 - 14:00 -
CrownBio Launches New Humanized Target Model for Immunotherapy
26/04/2018 - 14:00
Pages